Vimta Labs opened lower at ₹535.55, compared with its previous close of ₹538.30. During today's session, the stock has traded between ₹508.00 and ₹540.25, with an average traded price of ₹525.98. It is currently showing a downward intraday trend.
An investment of ₹10,000 made 5 years ago in Vimta Labs is now worth
₹ 35,217.00
giving a profit of
₹ 25,217.00 (252.17%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-6.70 (-1.24%)
Day High
₹540.25
Day Low
₹508.00
Day Open
₹535.55
Prev Close
₹538.30
Volume
1,74,640
Value Traded
₹9.19 Cr
1W Return
-7.02%
1M Return
-15.57%
3M Return
-6.09%
6M Return
14.78%
1Y Return
-25.02%
Market Cap (₹ Cr.)
2,376
PE Ratio
30.20
PB Ratio
5.26
Dividend Yield
0.37%
ROE
12.83%
ROCE
16.36%
Book Value (₹)
102.21
Face Value (₹)
2.00
EPS (TTM)
9.65
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-7.02%
6 Week
-
1 Month
-15.57%
3 Month
-6.09%
9 Month
-5.49%
Vimta Labs schedules analyst meets with Oppenheimer, Abakkus in September
Vimta Labs hosts analyst meet with Oppenheimer on September 4. Virtual meeting scheduled with Abakkus Asset Management on September 9. Discussions focus on business operations without sharing UPSI.
1mo agoVimta Labs schedules analyst meets for July 31
Vimta Labs Limited announced virtual analyst meetings for July 31, 2026, involving Nine Rivers Capital and Vaikarya Change. The sessions focus on business operations, with no UPSI shared, in compliance with SEBI Regulation 30.
2mo agoVimta Labs Q1FY27 PAT rises 11.4% to ₹210.42 Mn
Vimta Labs Limited reported a 13.7% year-on-year increase in total income to ₹1,128.86 Mn for Q1 FY27, with net profit rising 11.4% to ₹210.42 Mn. EBITDA improved to ₹283.38 Mn, expanding margins to 36.4%. Despite sequential margin compression due to facility costs and rupee appreciation, management maintained a 20-25% revenue growth target for the year. Operational highlights include the commencement of Biologics CRADS and a regulatory audit from Ukraine.
2mo agoVimta Labs to hold Q1FY27 earnings call on July 20
Vimta Labs has announced an analyst and investor conference call for July 20, 2026, at 4:00 PM IST to discuss its unaudited financial results for the quarter ended June 30, 2026. The call will feature key management members including the Managing Director, Executive Director, CFO, and Company Secretary. Domestic and international dial-in numbers, along with a DiamondPass™ option for direct connection, have been provided for participants.
2mo agoVimta Labs pays ₹2 dividend for FY26
Vimta Labs Limited distributed a dividend of ₹2 per share for FY26 on July 4, 2026, after securing shareholder approval at the Annual General Meeting.
3mo agoVimta Labs confirms no encumbrance on promoter shares in FY26
Vimta Labs disclosed that its promoters and persons acting in concert did not encumber any shares during the financial year ended March 31, 2026. The confirmation, submitted by Dr S P Vasireddi, complies with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing was communicated to the BSE and NSE by Company Secretary Sujani Vasireddi.
3mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹379.55 | +2.04% | ₹15,321.26 | 67.96 | -41.72% | |
| ₹580.70 | -0.90% | ₹13,992.94 | 35.18 | +4.32% | |
| ₹283.75 | -0.82% | ₹8,017.72 | -22.96 | +35.50% | |
| ₹91.15 | -2.00% | ₹214.61 | -35.08 | +43.09% | |
| ₹12.06 | -4.96% | ₹178.41 | 14.66 | -25.23% |
An investment of ₹10,000 made 5 years ago in Vimta Labs is now worth
₹ 35,217.00
giving a profit of
₹ 25,217.00 (252.17%)
Note: Past profits do not guarantee future returns.
